- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/70 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving creatine or creatinine
Patent holdings for IPC class G01N 33/70
Total number of patents in this class: 317
10-year publication summary
|
17
|
21
|
29
|
48
|
19
|
31
|
25
|
27
|
29
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20590 |
15 |
| Roche Diagnostics Operations, Inc. | 1510 |
11 |
| Instrumentation Laboratory Company | 249 |
8 |
| Radiometer Medical ApS | 187 |
8 |
| Siemens Healthcare Diagnostics Inc. | 2129 |
7 |
| F. Hoffmann-La Roche AG | 7847 |
6 |
| Mars, Incorporated | 2885 |
6 |
| Roche Diagnostics GmbH | 2702 |
5 |
| bioMerieux, Inc. | 449 |
5 |
| IDEXX Laboratories, Inc. | 885 |
5 |
| Quest Diagnostics Investments LLC | 430 |
5 |
| Sysmex Corporation | 1436 |
5 |
| Healthy.io Ltd | 81 |
5 |
| Laboratory Corporation of America Holdings | 829 |
4 |
| Abbott Diabetes Care Inc. | 2064 |
3 |
| Panasonic Corporation | 19386 |
3 |
| Bayer AG | 3470 |
3 |
| The Trustees of Columbia University in the City of New York | 3627 |
3 |
| Denka Seiken Co., Ltd. | 80 |
3 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3333 |
3 |
| Other owners | 204 |